Enveda’s discovery engine integrates deep learning, high-content biology, and the largest digitized natural-chemistry library to rapidly identify drug candidates across multiple therapeutic areas. This talk will explore the company’s growing clinical pipeline, including ENV-308 for obesity, and outline how AI is enabling strategic partnerships and accelerating first-in-human timelines.